Variant report
Variant | esv3393532 |
---|---|
Chromosome Location | chr2:116043732-116044780 |
allele | n/a |
Outlinks | Ensembl   UCSC |
- TF binding region (count:0)
- CpG islands (count:0)
- Chromatin interactive region (count:0)
- LncRNA region (count:0)
- Mature miRNA region (count: 0)
- miRNA target sites (count:0)
No data |
No data |
No data |
No data |
No data |
No data |
No data |

No. | Variant name | Chromosome position | Chromatin state | Related regulatory elements | Target genes | Extended variants | Associated traits |
---|---|---|---|---|---|---|---|
1 | rs141340141 | chr2:116043732-116043733 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
2 | rs545630233 | chr2:116043738-116043739 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
3 | rs376060164 | chr2:116043775-116043776 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
4 | rs190145844 | chr2:116043819-116043820 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
5 | rs182038714 | chr2:116043856-116043857 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
6 | rs541339587 | chr2:116043941-116043942 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
7 | rs115582031 | chr2:116043998-116043999 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
8 | rs370816648 | chr2:116044005-116044006 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
9 | rs186416973 | chr2:116044040-116044041 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
10 | rs36156428 | chr2:116044057-116044058 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
11 | rs200178210 | chr2:116044064-116044065 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
12 | rs70941040 | chr2:116044068-116044069 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
13 | rs11123294 | chr2:116044069-116044070 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
14 | rs57294144 | chr2:116044077-116044078 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
15 | rs60213155 | chr2:116044078-116044079 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
16 | rs59779482 | chr2:116044079-116044080 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
17 | rs60873127 | chr2:116044082-116044083 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
18 | rs70941041 | chr2:116044089-116044090 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
19 | rs201209703 | chr2:116044102-116044103 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
20 | rs568213243 | chr2:116044103-116044104 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
21 | rs7600222 | chr2:116044118-116044119 | Weak transcription | n/a | n/a | LD-proxies of rSNPOverlapped rCNV | n/a |
22 | rs549845431 | chr2:116044122-116044123 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
23 | rs77266913 | chr2:116044237-116044238 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
24 | rs555026615 | chr2:116044288-116044289 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
25 | rs375634167 | chr2:116044310-116044311 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
26 | rs552309921 | chr2:116044373-116044374 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
27 | rs565754929 | chr2:116044433-116044434 | Weak transcription Enhancers | n/a | n/a | Overlapped CNVs | n/a |
28 | rs371363438 | chr2:116044459-116044460 | Weak transcription Enhancers | n/a | n/a | Overlapped CNVs | n/a |
29 | rs534891362 | chr2:116044496-116044497 | Weak transcription Enhancers | n/a | n/a | Overlapped CNVs | n/a |
30 | rs74618683 | chr2:116044511-116044512 | Weak transcription Enhancers | n/a | n/a | Overlapped CNVs | n/a |
31 | rs568048009 | chr2:116044553-116044554 | Weak transcription Enhancers | n/a | n/a | Overlapped CNVs | n/a |
32 | rs149628763 | chr2:116044557-116044558 | Weak transcription Enhancers | n/a | n/a | Overlapped CNVs | n/a |
33 | rs7562421 | chr2:116044587-116044588 | Weak transcription Enhancers | n/a | n/a | LD-proxies of rSNPOverlapped rCNV | n/a |
34 | rs571974422 | chr2:116044597-116044598 | Weak transcription Enhancers | n/a | n/a | Overlapped CNVs | n/a |
35 | rs111309932 | chr2:116044654-116044655 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
36 | rs114095407 | chr2:116044659-116044660 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
37 | rs144396487 | chr2:116044740-116044741 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
Disease | PMID | Source |
---|---|---|
Medulloblastoma | 21979893 | CNVD |
Breast cancer | 17603634 | CNVD |
Ewing''s sarcoma | 21437220 | CNVD |
Glioblastoma multiforme | 21080181 | CNVD |
Ependymoma | 16718352 | CNVD |
Prostate cancer | 18632612 | CNVD |
Thoracic aortic aneurysm | 21092924 | CNVD |
Intellectual disability | 22102821 | CNVD |
Cancer | 20164919 | CNVD |
Autism | 22495311 | CNVD |
Autism | 18522746 | CNVD |
Neurodevelopmental disorder | 22521361 | CNVD |
Melanoma | 18172304 | CNVD |
Cancer | 16751803 | CNVD |
T-cell prolymphocytic leukemia | 19278963 | CNVD |
Acute lymphoblastic leukemia | 20067559 | CNVD |
Acute lymphoblastic leukemia | 21980252 | CNVD |
Non-syndromic sensorineural hearing loss | 15273396 | CNVD |
Seminomas | 18059402 | CNVD |
Testicular germ cell tumor | 18059402 | CNVD |
Myxofibrosarcoma | 16751306 | CNVD |
Breast cancer | 16272173 | CNVD |
Lung cancer | 18438408 | CNVD |
Mowat-Wilson syndrome | 21572526 | CNVD |
Disorders of sex development | 21048976 | CNVD |
epilepsy | 18472482 | CNVD |
Ewing''s sarcoma | 17952124 | CNVD |
Hepatocellular carcinoma | 16750200 | CNVD |
Cancer | 21637783 | CNVD |
Non-syndromic sensorineural hearing loss | 18471307 | CNVD |
Esophageal squamous carcinoma | 21637470 | CNVD |
Liposarcoma | 21253554 | CNVD |
Endometrial cancer | 22040021 | CNVD |
Breast cancer | 21264507 | CNVD |
Embryonal rhabdomyosarcoma | 16790082 | CNVD |
Autism | 16446308 | CNVD |
Autism | 19401682 | CNVD |
lymphocytic leukemia | 21291569 | CNVD |
Splenic marginal zone lymphoma | 21957467 | CNVD |
Basal cell lymphoma | 16317097 | CNVD |
Diffuse large b-cell lymphoma | 16317097 | CNVD |
Colorectal cancer | 16272173 | CNVD |
myoclonus epilepsy | 18472482 | CNVD |
Benign familial neonatal-infantile seizures | 18472482 | CNVD |
Diffuse large b-cell lymphoma | 18287131 | CNVD |
small cell lung cancer | 20016488 | CNVD |
Acute myeloid leukemia | 20729466 | CNVD |
Myelofibrosis | 22110671 | CNVD |
Neuroticism | 17667963 | CNVD |
Breast cancer | 22522925 | CNVD |
Pancreatic cancer | 17952125 | CNVD |
Hodgkin''s lymphoma | 17606441 | CNVD |
Pancreatic ductal adenocarcinoma | 19077451 | CNVD |
Mental retardation | 17621639 | CNVD |
No. | Chromosome Location | Chromatin state | Cell line | Tissue |
---|---|---|---|---|
1 | chr2:116043000-116051600 | Weak transcription | ES-I3 Cell Line | embryonic stem cell |
2 | chr2:116043400-116044400 | Weak transcription | hESC Derived CD56+ Mesoderm Cultured Cells | ES cell derived |
3 | chr2:116043400-116052400 | Weak transcription | hESC Derived CD184+ Endoderm Cultured Cells | ES cell derived |
4 | chr2:116044400-116044600 | Enhancers | hESC Derived CD56+ Mesoderm Cultured Cells | ES cell derived |